5 Followers on Owler

Immunovant

is a New York-based biotechnology company that researches and develops novel therapeutics for the treatment of autoimmune diseases... Read more
OverviewCompetitorsFundingNews & Insights

Immunovant

is a New York-based biotechnology company that researches and develops novel therapeutics for the treatment of autoimmune diseases... Read more
Immunovant CEO: Pete Salzmann

CEO

Pete Salzmann

CEO Approval Rating

90/100

2018

PublicAcquired by Health Sciences Acquisitions Corp.NASDAQIMVT

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
<$1M
Employees
120
Funding
$1.3B

News

Funding
Jan 14, 2025
Securities and Exchange Commission
Immunovant received $450M in Post-IPO Equity Funding

Immunovant Competitors

1Sutro Biopharma
2Cue Biopharma
3Artax Biopharma
4Affibody Medical
5Alexion
6argenx
Unlock 3 + competitors

Trending Companies